Treace Medical Concepts Inc

Treace Medical Concepts Inc

TMCI

Get informed when a big investor buys or sells

+ Follow
Market Cap$224.46M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Treace Medical Concepts IncTreace Medical Concepts Inc-3.7--79%1.10.2
$-1.53

Current Fair Value

145% downside

Overvalued by 145% based on the discounted cash flow analysis.

Share Statistics

Market cap$224.46 Million
Enterprise Value$228.47 Million
Dividend Yield$- (-)
Earnings per Share$-0.93
Beta1.11
Outstanding Shares64,592,681

Return

Return on Equity-79.08%ROE
Return on Assets-33.16%
Return on Invested Capital-38.07%

Valuation & Multiples

P/E Ratio-3.66P/E Ratio
PEG-28.59PEG
Price to Sales1.13Price to Sales
Price to Book Ratio3.4Price to Book Ratio
Enterprise Value to Revenue1.1
Enterprise Value to EBIT-4.01
Enterprise Value to Net Income-4
Total Debt to Enterprise0.06
Debt to Equity0.18Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-0.31
Average shareholder expectation
Revenue Estimate
$45.96 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$43.94 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 646.63%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %56.35% 0.00%
Total Invested$48.30M 44.99%
Investors Holding116 2.00%

ESG Score

No data

About Treace Medical Concepts Inc

133 employees

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion ...